ApplePhenon is a proprietary extract of apples wild-harvested in central Asia. Its phytochemical profile is characterized by an oligomeric and polymeric procyanidin fraction, which is shown to act synergistically with non-absorbable polymeric procyanidins fraction, boosting the bioavailability of the absorbable fraction. It also modulates gut microbiota to benefit this activity, and has been clinically validated for seven separate health benefits over the course of 17 clinical studies.
The current study was a randomized, double-blind, placebo-controlled trial examining the effect of ApplePhenon on skin health in 59 healthy women over the course of 12 weeks, at dosages of 300 mg and 600 mg per day.
ApplePhenon resulted in a reduction in skin reddening after UV irradiation of the treatment groups compared to the placebo group, measured as the delta increase in redness. There was a significantly lower delta increase in melanin formation after UV irradiation in the treatment group versus the placebo group, as well as less skin darkening due to UV irradiation in the treatment groups. The study also found that ApplePhenon has SOD-like antioxidant activity, based on results which indicated that all of the oligomer fractions present in ApplePhenon strongly inhibited the generation of superoxide radicals.
“These results indicate an internal sunscreen effect and antioxidant protection by ApplePhenon in the skin of healthy women,” BGG said in a statement.